Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03745248 · ClinicalTrials.gov registry record · NA

Aerobic Exercise, Balance Training, and Ataxia

A NA study of Spinocerebellar Ataxias and Ataxia, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT03745248 is a NA study of Spinocerebellar Ataxias and Ataxia that has completed, run by Columbia University. The registered enrollment target is 20 participants, below the 475-participant average among 5 other Spinocerebellar Ataxias trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03745248, a NA study of Spinocerebellar Ataxias and Ataxia, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The first aim is to show aerobic training improves degenerative cerebellar patients functionally The second aim is to compare the effects of balance and aerobic training on degenerative cerebellar disease.

Interventions

  • BEHAVIORAL Balance Training
  • BEHAVIORAL Aerobic training

Study Locations (1)

New York

  • Columbia University/New York Presbyterian - New York

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-11-14
Est. Completion 2019-10-14
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03745248

The ClinicalTrials.gov registry entry for NCT03745248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 5 other Spinocerebellar Ataxias trials with a reported enrollment target (96% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinocerebellar Ataxias appearing as the primary indexed condition, and to 2 interventions - of which Balance Training is the first listed.

NCT03745248 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03745248 about?

NCT03745248 is a clinical study titled "Aerobic Exercise, Balance Training, and Ataxia". The first aim is to show aerobic training improves degenerative cerebellar patients functionally The second aim is to compare the effects of balance and aerobic training on degenerative cerebellar disease.

What is the current status of trial NCT03745248?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-11-14. Estimated completion is 2019-10-14.

What conditions does trial NCT03745248 study?

This clinical trial studies the following conditions: Spinocerebellar Ataxias, Ataxia, Spino Cerebellar Degeneration.

What interventions are being tested in trial NCT03745248?

The interventions under investigation include: Balance Training (BEHAVIORAL), Aerobic training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03745248?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03745248 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinocerebellar Ataxias

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.